Public funding for biomedical research is often justified as a means to encourage development of more (and better) treatments for disease. However, few studies have investigated the relationship between these expenditures and downstream pharmaceutical innovation. In particular, although recent analyses have shown a clear contribution of federally…

The analysis of costs of National Institutes of Health (NIH) bio-medical research demonstrates that the increased expenditures for research project grants are due to such factors as real growth in the program, artifacts of the calculation method, and the extent to which project periods of awards have lengthened. (Author/DB)

Discussion of academic medical centers (AMCs) looks at: change due to heavy federal funding in recent decades; adverse consequences, including deemphasis on education in favor of research and clinical service delivery, and discrepancies between AMC internal and external labor markets; and challenges to medical education in research, education, and…